Effectiveness of Acapella and ELTGOL Technique to Promote Airway Clearance in COPD:a Comparative Study
NCT ID: NCT02249455
Last Updated: 2014-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2014-07-31
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Activity of Inspiratory Muscles With the Use of Positive Pressure in Patients With Chronic Obstructive Pulmonary Disease
NCT01111487
Results of Manual Therapy on Pulmonary Parameters
NCT01735474
Effect of NMES on Quadriceps Muscle Strength and Endurance in Patients With COPD
NCT05539547
Selective Manual Therapy Techniques in Chronic Obstructive Pulmonary Disease
NCT05781867
Comparison of Two Methods of Adjusting the Mechanical In-Exsuflation in Neuromuscular Adult Patients
NCT03355105
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acapella
Acapella is given to the patients twice daily for 20 min.
Acapella
Treatment time for 20 min twice daily
ELTGOL
Expiration with open glottis in lateral position is done twice daily for 20 min
ELTGOL
ELTGOL technique 20 min twice daily
conventional physiotherapy
Conventional physiotherapy like breathing exercise, active coughing, chest mobilisation was encouraged twice daily for 20 min.
conventional physiotherapy
Conventional physiotherapy was given twice daily for 20 min
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acapella
Treatment time for 20 min twice daily
ELTGOL
ELTGOL technique 20 min twice daily
conventional physiotherapy
Conventional physiotherapy was given twice daily for 20 min
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Moderate copd
* Patient able to sustain expiratory flow greater than 15l/min
* Patient expectorate more than 25.-30ml
Exclusion Criteria
* Peripheral oxygen saturation lower than 85%
* Rr\>35breaths/min
* Current acute chest pain
* Recent history of haemoptysis
30 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
PSG College of Physiotherapy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
STEFFI VARGHESE P
post graduate in cardiopulmonary rehabiltation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
steffi varghese, mpt
Role: PRINCIPAL_INVESTIGATOR
psg ims&r
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Steffi Varghese
Coimbatore, Tamil Nadu, India
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
mahesh, mpt
Role: primary
shanmugapriya, mpt
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14\305
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.